Digital Health New Zealand

New Zealand Genomic Data Analysis Software Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

New Zealand Genomic Data Analysis Software Market Industry Trends and Forecast to 2034: Segmented by (Function, Deployment, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.1 Mn Placeholder estimate
Estimate 2025 $27.0 Mn 1% of the global market
Projected 2034 $108.3 Mn 301.5% Adds $81.3 Mn over 9 forecast years
CAGR 2025–2034 16.7% Faster than 57% of 61 Digital Health markets here
Key players 5
  • New Zealand is 0.98% of the global market.
  • In APAC, the largest is China at $213.0 Mn.
  • Fastest growing: India at 20.3% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$81.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Genomic Data Analysis Software Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.1 Mn — —
2025 (base) $27.0 Mn +$3.9 Mn —
2026 (forecast) $31.5 Mn +$4.5 Mn +16.7%
2027 (forecast) $36.7 Mn +$5.3 Mn +36.2%
2028 (forecast) $42.9 Mn +$6.1 Mn +58.9%
2029 (forecast) $50.0 Mn +$7.2 Mn +85.5%
2030 (forecast) $58.4 Mn +$8.4 Mn +116.4%
2031 (forecast) $68.1 Mn +$9.7 Mn +152.6%
2032 (forecast) $79.5 Mn +$11.4 Mn +194.8%
2033 (forecast) $92.8 Mn +$13.3 Mn +244%
2034 (forecast) $108.3 Mn +$15.5 Mn +301.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand Genomic Data Analysis Software Market Analysis at a glance
Market size, 2025$27.0 Mn placeholder estimate
Forecast, 2034$108.3 Mn placeholder estimate
Growth (CAGR), 2025–203416.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledGenomics Data Analysis
SegmentsFunction, deployment and end user (see all)
Key playersIllumina, Inc., Qiagen N.V., DNAnexus, Seven Bridges (Velsera), Fabric Genomics (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Genomic Data Analysis Software Market Analysis Executive Summary

Genomic data analysis software turns raw DNA sequencing data into reports and insights for labs, doctors and researchers.

Key segments of the genomic Data Analysis Software market include function (Variant Calling, Interpretation and Reporting and Data Management) and deployment (Cloud and On-Premise).

Bar chart: New Zealand Genomic Data Analysis Software market size, 2024–2034, placeholder estimates. $23.1 Mn in 2024, $27.0 Mn in 2025 and $108.3 Mn in 2034, 16.7% CAGR.
New Zealand Genomic Data Analysis Software market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Genomic Data Analysis Software Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the genomic Data Analysis Software market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the genomic Data Analysis Software market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the genomic Data Analysis Software market.

Competitive Landscape for Genomic Data Analysis Software Market in New Zealand

The genomic Data Analysis Software market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Genomic Data Analysis Software Market in New Zealand

Genomic Data Analysis Software in New Zealand: payment

Pharmac decides which medicines and medical devices the public health system pays for.⁠[1]

[1] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the genomic Data Analysis Software market. Government digital health programs in New Zealand are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Genomic Data Analysis Software right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Genomic Data Analysis Software in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Genomic Data Analysis Software market in New Zealand?
Placeholder estimate: about $27.0 Mn in 2025, rising to about $108.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Genomic Data Analysis Software market in New Zealand growing?
Placeholder estimate: about 16.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Genomic Data Analysis Software market report cover?
The report splits the market by function (Variant Calling, Interpretation and Reporting, Data Management, AI Analytics), deployment (Cloud, On-Premise) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Genomic Data Analysis Software market?
Key players include Illumina, Inc., Qiagen N.V., DNAnexus, Seven Bridges (Velsera) and Fabric Genomics.
What is driving the Genomic Data Analysis Software market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the genomic Data Analysis Software market.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Genomic Data Analysis Software?
PubMed lists 42 papers on Genomic Data Analysis Software added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in New Zealand

See all

Related on genomics and health it and data

See the topic